Page last updated: 2024-08-22

angiotensin ii and guanosine monophosphate

angiotensin ii has been researched along with guanosine monophosphate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Dillon, JF; Hayes, PC; Henderson, N; Jalan, R; O'Rourke, K; Redhead, DN; Thomas, HW; Williams, BC1
Fukai, D; Hisanaga, T; Kinoshita, M; Mabuchi, N; Maeda, K; Maeda, Y; Ohnishi, M; Tsutamoto, T; Wada, A1
Kimura, M; Nakashima, M; Ohashi, K; Umemura, K1
Kahn, AM; Yang, M1
Chen, PP; Deng, J; Gao, Y; Gong, QH; Li, YY; Lin, HC; Luo, M; Shi, WL; Wen, ZQ; Xu, RX; Xu, SF1
Lee, SK; Ling, WC; Mohd Sabri, NA; Murugan, DD1

Trials

1 trial(s) available for angiotensin ii and guanosine monophosphate

ArticleYear
Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    American heart journal, 1997, Volume: 134, Issue:5 Pt 1

    Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Cardiotonic Agents; Deslanoside; Female; Guanosine Monophosphate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Norepinephrine; Renin

1997

Other Studies

5 other study(ies) available for angiotensin ii and guanosine monophosphate

ArticleYear
Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS).
    European journal of gastroenterology & hepatology, 1996, Volume: 8, Issue:11

    Topics: Adult; Angiotensin II; Ascites; Female; Guanosine Monophosphate; Humans; Kidney Function Tests; Lithium; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Prognosis; Prospective Studies; Radioimmunoassay; Reference Values; Renin; Severity of Illness Index; Sodium

1996
Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
    The Canadian journal of cardiology, 1998, Volume: 14, Issue:1

    Topics: Angiotensin II; Animals; Aortic Diseases; Blood Pressure; Cardiomegaly; Disease Models, Animal; Guanosine Monophosphate; Male; Protease Inhibitors; Rats; Rats, Wistar; Thiorphan

1998
Insulin-inhibited and stimulated cultured vascular smooth muscle cell migration are related to divergent effects on protein phosphatase-2A and autonomous calcium/calmodulin-dependent protein kinase II.
    Atherosclerosis, 2008, Volume: 196, Issue:1

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Movement; Cells, Cultured; Guanosine Monophosphate; Insulin; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Protein Phosphatase 2; Rats; Rats, Sprague-Dawley

2008
Sodium Ferulate Inhibits Rat Cardiomyocyte Hypertrophy Induced by Angiotensin II Through Enhancement of Endothelial Nitric Oxide Synthase/Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway.
    Journal of cardiovascular pharmacology, 2022, 08-01, Volume: 80, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Coumaric Acids; Cyclic GMP; Esters; Guanosine Monophosphate; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Signal Transduction

2022
Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS.
    Scientific reports, 2022, 10-21, Volume: 12, Issue:1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Cyclic GMP; Endothelium, Vascular; Guanosine Monophosphate; Hypertension; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species

2022